Biotech and Pharma Company Funding via IPO/SPAC

This listing is for a corporate finance advisory firm specializing in arranging equity funding for Biotech and Pharma companies. They connect businesses with investment funds, contingent on successful listing on EU or NASDAQ exchanges. The service includes guidance on listing costs (approx. EUR 150K for EU, USD 500K+ for NASDAQ) and can facilitate funding amounts ranging from EUR 5M to 200M. Additionally, they can source public shell companies in Germany, Switzerland, France, or the UK. The firm operates exclusively on a success fee basis.